EASL Liver Cancer Summit 2025

位置: Paris, France

日期:

活动简介:

Novotech will attend the EASL Liver Cancer Summit 2025, a key event focused on advancements in liver cancer research and treatment. Discussions will cover recent progress in primary liver cancer, with a focus on hepatocellular carcinoma and cholangiocarcinoma, as well as innovations in immunotherapy, systemic therapies, and artificial intelligence-driven diagnostics. 

As a specialized contract research organization (CRO), Novotech provides: 

  • Strong investigator networks to quickly identify optimal trial sites for liver disease studies 
  • 25 years of experience delivering high-quality CRO services for biotechnology companies 
  • A biotech-focused approach tailored to support liver disease clinical research 

Meet Lotfi Rachedi, Regional Director, Business Development 

Lotfi Rachedi will be available to discuss Novotech’s expertise in liver disease clinical trials and how its tailored approach can support biotechnology companies. 

Schedule a meeting via the MyEASL app

与我们的参会人员预约会面

参会人员

Novotech

Lotfi Rachedi

Novotech
Regional Director Business Development

此外，还有来自Novotech中国、客户运营团队、Novotech药物开发咨询团队以及美国与欧洲商务拓展团队的资深团队成员。